Qura secures €1.5M to rethink health management in Europe

March 3, 2026 at 09:00 AM UTC
Tech.eu
Original: EN
Qura secures €1.5M to rethink health management in Europe

Milan-based Qura has secured €1.5 million in pre-seed funding to enhance its AI-powered health management platform, addressing a significant gap in European healthcare. This investment, led by United Ventures and supported by other notable investors, signals growing confidence in technology-driven solutions for preventative health and the management of subclinical conditions. Qura's initiative aligns with a broader European trend towards digital health innovation, aiming to provide more accessible and personalized care pathways. The platform is designed to tackle the prevalent issue of persistent subclinical symptoms that affect a substantial portion of the adult population but are often inadequately addressed by traditional primary care. By integrating comprehensive blood testing, AI-driven diagnostics, and extensive physician consultations, Qura offers personalized health plans and ongoing medical guidance. This hybrid model leverages AI for efficiency and personalization while keeping physicians central to patient care, fostering trust and improving adherence to health recommendations. This development is particularly relevant given the projected growth of Europe's health check-up market to €18.6 billion by 2030, indicating a strong demand for preventative health services. Qura's EU-native platform prioritizes regulatory compliance, including GDPR, and aims to build a medically validated infrastructure integrated with local healthcare networks. The funding will support Qura's expansion in hiring, AI development, and entry into new European markets, further strengthening the continent's digital health ecosystem and offering European alternatives to existing health management solutions.

Curated and translated by Europe Digital for our multilingual European audience.

Source Information

Publication: Tech.eu
Published: March 3, 2026 at 09:00 AM UTC
All rights remain with the original publisher.